Portal Innovations CEO on Future of US Medical Research

The Trump administration is advancing a plan to allocate $200 billion annually toward medical research, emphasizing support for individual scientists and private research facilities rather than traditional university-based research. John Flavin, CEO of Portal Innovations, a Chicago-based firm that funds early-stage life sciences companies, discussed the implications of this shift. He speaks with Romaine Bostick on "The Close." (Source: Bloomberg)